Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
The purpose of this study was to quantify the free-circulating plasma HER-2 DNA (cfHER-2 DNA) and to assess the ability of analysis to discriminate between patients with primary breast cancer and healthy controls in order to detect metastatic recurrence in comparison with serum HER-2 protein and als...
Main Authors: | Patricia Diana Sørensen, Rikke Fredslund Andersen, Niels Pallisgaard, Jonna Skov Madsen, Erik Hugger Jakobsen, Ivan Brandslund |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2015-08-01
|
Series: | Journal of Circulating Biomarkers |
Online Access: | https://doi.org/10.5772/61320 |
Similar Items
-
Quantification of Cell-free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
by: Patricia Diana Sørensen, et al.
Published: (2015-08-01) -
New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer
by: Peer Horn, et al.
Published: (2014-12-01) -
Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer.
by: Karen Lise Garm Spindler, et al.
Published: (2015-01-01) -
MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
by: Anne Haahr Mellergaard Eriksen, et al.
Published: (2016-01-01) -
Quantification of microRNA levels in plasma - Impact of preanalytical and analytical conditions.
by: Helle Glud Binderup, et al.
Published: (2018-01-01)